News
IMHL participant spearheads TB vaccine trial in Mumbai
Published: 6 September 2019
Dr. Daksha Shah (IMHL’20) is leading a new TB vaccine trial in Mumbai, where an estimated 40 to 50 percent of the population carries a latent TB infection. The pilot project focuses on providing treatment to close contacts of TB patients.
Feedback
For more information or if you would like to report an error, please web.desautels [at] mcgill.ca (subject: Website%20News%20Comments) (contact us).
